Peter Schirmacher

Academic Education and scientific Degrees

1996 Habilitation (Pathology), University of Mainz

1989-1991 PhD-Study (Molecular Biology), Albert Einstein College of Medicine, New York

1987 MD-Thesis, Institute of Physiology, University of Mainz

1981-1987 Study of Medicine, University of Mainz

Professional Career

Since 2004 Professor of Pathology (C4) and Director, Institute of Pathology, Heidelberg University

1998-2004 Professor of Pathology (C3), Deputy Director, Institute of Pathology, Cologne University

1996 Board Certification Molecular Pathology

1996 Habilitation (venia legendi) in Pathology

1995 Board Certification Pathology

1991-1998 Research Associate, Institute of Pathology, University of Mainz

1989-1991 Postdoctoral Research Fellowship (DFG); Liver Research Center, Albert Einstein College of Medicine, Yeshiva University, New York

1987-1989 Research Associate, Institute of Pathology, University of Mainz

Others

Since 2024 Director, International Cooperation on Cancer Reporting (ICCR)

Since 2022 Board member, genomDE

Since 2018 Director, Center for Personalized Medicine Heidelberg (ZPM); Board member and Deputy Speaker Centers of Personalized Medicine Baden-Württemberg (ZPM-BW); Board Member German Network for Personalized Medicine (DNPM)

2017-23 Coordinator of the Consortional Research Grant SFB/TR209 “Liver Cancer” (DFG)

Since 2015 Board member European Society of Pathology (ESP), President (2023-25), Executive Committee (since 2021)

Since 2015 Board member National Center of Tumor Diseases (NCT)

2014-2020 Board Member German Telematics Platform (TMF)

2013-2018 Board Member International Liver Cancer Association (ILCA)

Since 2012 President (2012-13) and Chairman (2013-19), German Society of Pathology (DGP), since 2019 Speaker, Working Group Pathology Chairs of German Universities

2011-2012 President International Laennec Society of Liver Pathology

Since 2011 Board Member, German Liver Foundation

Since 2011 Founder and Coordinator, Centralized BioMaterialBank Heidelberg (BMBH)

Since 2010 Coordinator of Biobanking Platforms, German Consortium for Translational Cancer Research (DKTK; 2010-2017) and German Center for Infectious Diseases Research (DZIF, since 2010), and Inter-DZG-Working Group Biobanking

2010-2014 Coordinator of the Consortional Research Grant SFB/TR77 “Liver Cancer” (DFG)

2008-2016 Member and Speaker (2008-2012) of Section 2 (Cancer and Stem Cell Research), German Research Foundation (DFG)

2007-2009 Board Member German Association for Study of the Liver (President 2008-2009)

2007-2019 Board Member German Association of Pathology (DGP)

Since 2005 Founder and Speaker ‘Tissue Bank of the National Center of Tumor Diseases’

2001-2004 Managing board ‘Center for Molecular Medicine Cologne’ (CMMC)

1996-1998 Managing board Consortional Research Grant DFG-SFB 519